Tech Company Financing Transactions
Lineagen Funding Round
On 4/5/2013, Lineagen received $8 million in funding from private investors.
Transaction Overview
Company Name
Announced On
4/5/2013
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$7,994,064
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
2677 E Parleys Way
Salt Lake City, UT 84109
USA
Salt Lake City, UT 84109
USA
Phone
Website
Email Address
Overview
The company is developing a diagnostic platform that targets autism, multiple sclerosis, cancer and chronic obstructive pulmonary disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Paul
Vice President
Rena Vanzo
VP - Human Resources
Leanne Hill
VP - Operations
Mathew Harrison
VP - Sales
Jeffrey Knupp
Browse more venture capital transactions:
Prev: 4/5/2013: Salsa Labs venture capital transaction
Next: 4/5/2013: Pasteurization Technology Group venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions on this site are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs